Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

DHA Effects in Brain Development and Function.

Lauritzen L, Brambilla P, Mazzocchi A, Harsløf LB, Ciappolino V, Agostoni C.

Nutrients. 2016 Jan 4;8(1). pii: E6. doi: 10.3390/nu8010006. Review.

2.

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.

Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F.

PLoS One. 2014 May 7;9(5):e96905. doi: 10.1371/journal.pone.0096905.

3.

Omega-3 fatty acids and depression: scientific evidence and biological mechanisms.

Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, Caraci F.

Oxid Med Cell Longev. 2014;2014:313570. doi: 10.1155/2014/313570. Review.

4.

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.

Assies J, Mocking RJ, Lok A, Ruhé HG, Pouwer F, Schene AH.

Acta Psychiatr Scand. 2014 Sep;130(3):163-80. doi: 10.1111/acps.12265. Review.

5.

Emerging risk factors for postpartum depression: serotonin transporter genotype and omega-3 fatty acid status.

Shapiro GD, Fraser WD, Séguin JR.

Can J Psychiatry. 2012 Nov;57(11):704-12. Review.

6.

Relationship between depression and apolipoproteins A and B: a case-control study.

Sadeghi M, Roohafza H, Afshar H, Rajabi F, Ramzani M, Shemirani H, Sarafzadeghan N.

Clinics (Sao Paulo). 2011;66(1):113-7.

7.

Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.

Carney RM, Freedland KE, Stein PK, Steinmeyer BC, Harris WS, Rubin EH, Krone RJ, Rich MW.

Psychosom Med. 2010 Oct;72(8):748-54. doi: 10.1097/PSY.0b013e3181eff148.

8.

Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Paz-Filho G, Licinio J, Wong ML.

Rev Bras Psiquiatr. 2010 Jun;32(2):181-91. Review.

9.

Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study.

Assies J, Pouwer F, Lok A, Mocking RJ, Bockting CL, Visser I, Abeling NG, Duran M, Schene AH.

PLoS One. 2010 May 14;5(5):e10635. doi: 10.1371/journal.pone.0010635.

10.
11.

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS.

JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.

12.

Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels.

Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA.

Psychosom Med. 2008 Oct;70(8):856-62. doi: 10.1097/PSY.0b013e318188a01e.

13.

Menopause, the metabolic syndrome, and mind-body therapies.

Innes KE, Selfe TK, Taylor AG.

Menopause. 2008 Sep-Oct;15(5):1005-13. doi: 10.1097/01.gme.0b013e318166904e. Review.

14.

Depression and cardiovascular comorbidity.

Glassman AH.

Dialogues Clin Neurosci. 2007;9(1):9-17. Review.

Items per page

Supplemental Content

Support Center